Literature DB >> 19730928

A clinical, radiological and outcome study of status epilepticus from India.

J Kalita1, P P Nair, Usha Kant Misra.   

Abstract

The objective of this study is to evaluate the clinical and radiological characteristics and the outcome of status epilepticus (SE). 117 consecutive patients with SE were evaluated including their demographics, history of epilepsy, antiepileptic drug (AED) default, comorbidities, SE type and duration. The study included 22 children, 77 adults and 18 elderly patients with SE. Blood counts, serum chemistry, ECG, cranial MRI, cerebrospinal fluid and EEG were done. Patients were treated with IV phenytoin, valproate, lorazepam or diazepam as per a fixed protocol and responses to first and second drugs were noted. Death during hospital was recorded. The etiology of SE was infection in 53.8%, drug default in 7.9%, metabolic in 14.5%, stroke in 12.8% and miscellaneous in 11% of patients. 92.3% of patients had convulsive and 7.7% nonconvulsive SE. Cranial MRI was abnormal in 62%. Infection as an etiology was more common in children, drug default and metabolic causes in adults and stroke in adults and elderly. Following first AED, SE was controlled in 50%. 30% of patients remained refractory to second AED which was related to duration of SE and mortality. 29% patients died and death was higher in elderly (44%) compared to children (14%). Acute symptomatic SE is more common in developing countries. Refractory SE is associated with SE duration and mortality.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19730928     DOI: 10.1007/s00415-009-5298-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  34 in total

1.  Causes and consequences of status epilepticus in adults. A study of 86 cases.

Authors:  J M Oxbury; C W Whitty
Journal:  Brain       Date:  1971       Impact factor: 13.501

Review 2.  Status epilepticus in children.

Authors:  M R Roberts; J Eng-Bourquin
Journal:  Emerg Med Clin North Am       Date:  1995-05       Impact factor: 2.264

3.  Role of clinical, radiological, and neurophysiological changes in predicting the outcome of tuberculous meningitis: a multivariable analysis.

Authors:  U K Misra; J Kalita; A K Roy; S K Mandal; M Srivastava
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

Review 4.  Epidemiology and outcomes of status epilepticus in the elderly.

Authors:  Alan R Towne
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

Review 5.  Status epilepticus: epidemiologic considerations.

Authors:  W A Hauser
Journal:  Neurology       Date:  1990-05       Impact factor: 9.910

6.  Clinical features of convulsive status epilepticus: a study of 220 cases in western China.

Authors:  L Chen; B Zhou; J M Li; Y Zhu; J H Wang; J W Sander; H Stefan; D Zhou
Journal:  Eur J Neurol       Date:  2009-04       Impact factor: 6.089

7.  Status epilepticus in children, adults, and the elderly.

Authors:  R J DeLorenzo; A R Towne; J M Pellock; D Ko
Journal:  Epilepsia       Date:  1992       Impact factor: 5.864

8.  Convulsive status epilepticus: clinical profile in a developing country.

Authors:  Jagarlapudi M K Murthy; Sita S Jayalaxmi; Meena A Kanikannan
Journal:  Epilepsia       Date:  2007-07-25       Impact factor: 5.864

9.  Determinants of mortality in status epilepticus.

Authors:  A R Towne; J M Pellock; D Ko; R J DeLorenzo
Journal:  Epilepsia       Date:  1994 Jan-Feb       Impact factor: 5.864

10.  Status epilepticus: clinical presentation, cause, outcome, and predictors of death in 119 Ethiopian patients.

Authors:  Amanuel Amare; Guta Zenebe; Julie Hammack; Gail Davey
Journal:  Epilepsia       Date:  2008-03-04       Impact factor: 5.864

View more
  11 in total

1.  Status epilepticus: Our experience in a tertiary care centre in Northwestern India.

Authors:  Ashish Bhalla; Biplab Das; Rimi Som; Sandeep Prabhakar; Parampreet S Kharbanda
Journal:  J Emerg Trauma Shock       Date:  2014-01

2.  Analysis of the delay components in the treatment of status epilepticus.

Authors:  Leena Kämppi; Harri Mustonen; Seppo Soinila
Journal:  Neurocrit Care       Date:  2013-08       Impact factor: 3.210

Review 3.  Epilepsy in India I: Epidemiology and public health.

Authors:  Senthil Amudhan; Gopalkrishna Gururaj; Parthasarathy Satishchandra
Journal:  Ann Indian Acad Neurol       Date:  2015 Jul-Sep       Impact factor: 1.383

4.  Practice parameters in management of status epileptics.

Authors:  Usha Kant Misra; Jayantee Kalita; Sanjeev Kumar Bhoi
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

5.  Epilepsy: Indian perspective.

Authors:  Nandanavana Subbareddy Santhosh; Sanjib Sinha; Parthasarathy Satishchandra
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

6.  Determinants of Outcome in Convulsive Status Epilepticus in Adults: An Ambispective Study from Central India.

Authors:  Raunak Dani; Ajoy Sodani; Kapil Telang; Richa Nigam
Journal:  Ann Indian Acad Neurol       Date:  2019 Jan-Mar       Impact factor: 1.383

7.  Need for a national epilepsy control program.

Authors:  M Tripathi; D C Jain; M Gourie Devi; S Jain; V Saxena; P S Chandra; K Radhakrishnan; M Behari; M Gupta; V Puri; M M Mehndiratta; K Bala; K S Anand; S Rawat; P U Shah; S Gulati; S Johri; V V Nadkarni; P Sarat Chandra; D Bachani
Journal:  Ann Indian Acad Neurol       Date:  2012-04       Impact factor: 1.383

8.  Treatment of recurrent epileptic seizures in patients with neurological disorders.

Authors:  Guan-Qian Yuan; Dan-Dan Gao; Jun Lin; Song Han; Bo-Chuang Lv
Journal:  Exp Ther Med       Date:  2012-11-01       Impact factor: 2.447

9.  Delays and Factors Related to Cessation of Generalized Convulsive Status Epilepticus.

Authors:  Leena Kämppi; Jaakko Ritvanen; Harri Mustonen; Seppo Soinila
Journal:  Epilepsy Res Treat       Date:  2015-08-10

Review 10.  Efficacy and safety of intravenous valproate for status epilepticus: a systematic review.

Authors:  Eugen Trinka; Julia Höfler; Alexander Zerbs; Francesco Brigo
Journal:  CNS Drugs       Date:  2014-07       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.